ARRHYTHMIA RESEARCH TECHNOLOGY, INC. Announces a 5-Year Supply AgreementiForma Device Detail (Graphic: Business Wire)Micron Manu
30 Julio 2007 - 7:00AM
Business Wire
Arrhythmia Research Technology, Inc. (AMEX: HRT) announced that its
wholly owned subsidiary Micron Products Inc. (�Micron�), has
entered into a five-year supply agreement with ConforMIS, Inc.
Micron, through it�s Micron Integrated Technologies and Leominster
Tool divisions, will provide manufacturing services for the
ConforMIS Knee Interpositional Device, the iForma�, for use in the
treatment of patients with early to moderate osteoarthritis.
ConforMIS develops unique, patient-specific implants capable of
re-establishing normal articular alignment and relieving pain in
patients with osteoarthritis of the knee. Each device is
manufactured to conform to an individual patient's unique anatomy,
allowing for maximum tissue preservation and minimal surgical
trauma. Preserving bone stock is especially important to younger
and more active individuals. The ConforMIS iForma is a small,
lightweight, personalized metal implant designed for patients with
early to moderate osteoarthritis in either the medial or lateral
compartment of the knee. It fits into the affected compartment
between the femur (thigh bone) and tibia (shin bone) and helps fill
the lost cartilage, restore the knee's proper alignment, and
prevent painful rubbing of the bones during ambulation. Its precise
fit to the structure of the joint allows the surgeon to easily
insert the device through a small incision, achieving functional
fixation without the need for cement or screws. The iForma allows
patients to return to light to moderate physical activities and
allows for easy revision to other procedures in the future, if
necessary. James E. Rouse, President and CEO of Arrhythmia Research
Technology, Inc., commented, �We are very pleased to have been
chosen by ConforMIS as the turn-key manufacturer of the iForma.
This opportunity to augment our manufacturing capabilities to
include finished medical devices represents just one success in the
continuing efforts of our business development team to expand and
diversify our business. The agreement calls for the iForma to be
the first in a series of ConforMIS products to be manufactured by
Micron and its divisions as we expand upon the close working
relationship that has developed between our two companies. Micron's
expansion into medical device manufacturing for an OEM customer
such as ConforMIS complements our proven capability as a high
quality manufacturer of components for medical products." Patrick
Hess, Ph.D, CEO of ConforMIS commented, �Micron provides us with
the manufacturing and service excellence to continue building our
unique value proposition to our customers. We evaluated a number of
manufacturers and found Micron�s flexible manufacturing operations
and commitment to helping us scale over time to be unique. Given
our rapid growth and patient-specific manufacturing process, we
were pleased to find a manufacturer who demonstrated a willingness
to work with us as partners.� About Arrhythmia Research Technology,
Inc. ART, through Micron, manufactures silver plated and non-silver
plated conductive resin sensors and distributes metal snaps used in
the manufacture of disposable ECG, EEG, EMS and TENS electrodes.
Micron�s NEM division manufactures custom injection molded products
for medical, electronic, industrial and consumer applications.
Micron�s MIT division provides end- to- end product life cycle
management through a comprehensive portfolio of value-added
services such as design, engineering, prototyping, manufacturing,
machining, assembly and packaging. Micron�s Leominster Tool
division provides high end mold design, manufacturing and precision
machining for various industries. The Company�s products also
include proprietary signal-averaging electrocardiography (SAECG)
software used in the detection of potentially lethal hearth
arrhythmias. For more information please check our websites:
http://www.arthrt.com http://www.micronproducts.com
http://www.leominstertool.com http://www.newenglandmolders.com
http://www.micronintegrated.com About ConforMIS, Inc. ConforMIS,
Inc., located outside Boston, MA, is a privately held medical
device company incorporated in 2004. Its mission is to provide
best-in-class, minimally invasive implants for orthopedics and
sports medicine through the use of its proprietary iFit
Technology�. The iFit Technology is a patent-protected,
software-enabled process for converting CT and MR imaging data into
conforming, patient-specific implants. This �image-to-implant�
technology allows for precisely sized and shaped implants that
reduce or eliminate the need for cartilage removal or bone
resection and radically simplify the surgical procedure. With over
100 allowed and pending patent applications, ConforMIS has
developed a portfolio of diverse, integrated intellectual property
and know-how spanning multiple aspects of musculoskeletal medicine
including: Imaging Software Image Processing Implant Design
Surgical Instrumentation Guidance Systems To date, the company has
developed a comprehensive line of minimally invasive bone and
cartilage preserving knee implants for all stages of osteoarthritis
with regulatory clearance from the US FDA and CE Mark in Europe.
For more information please check our website:
http://www.conformis.com. Note Regarding Forward Looking Statements
Forward-looking statements made herein are based on current
expectations of the Company that involve a number of risks and
uncertainties and should not be considered as guarantees of future
performance. The factors that could cause actual results to differ
materially include: interruptions or cancellation of existing
contracts, impact of competitive products and pricing, product
demand and market acceptance, risks, the presence of competitors
with greater financial resources than the Company, product
development and commercialization risks, changing economic
conditions in developing countries, and an inability to arrange
additional debt or equity financing. More information about factors
that potentially could affect the Company's financial results is
included in the Company's filings with the Securities and Exchange
Commission, including its Annual Report on Form 10-KSB for the year
ended December 31, 2006.
Micron Solutions (AMEX:MICR)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Micron Solutions (AMEX:MICR)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024